Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, the FDA issued a Warning Letter to Jinher, Inc., a dietary supplement manufacturer, on October 4, 2018. Without access to the full letter text or subject line, the specific nature of the violations cannot be detailed, though they likely relate to manufacturing, labeling, or marketing compliance issues common to dietary supplement enforcement. The warning falls under FDA's dietary supplement regulatory authority, though the specific issuing office is not identified in the available metadata.